VERMIDOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vermidol, and what generic alternatives are available?
Vermidol is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in VERMIDOL is piperazine citrate. There are eighteen drug master file entries for this compound. Additional details are available on the piperazine citrate profile page.
Summary for VERMIDOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 45 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VERMIDOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VERMIDOL
US Patents and Regulatory Information for VERMIDOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Solvay | VERMIDOL | piperazine citrate | SYRUP;ORAL | 080992-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |